302 related articles for article (PubMed ID: 32375361)
1. MicroRNA Nanotherapeutics for Lung Targeting. Insights into Pulmonary Hypertension.
Carregal-Romero S; Fadón L; Berra E; Ruíz-Cabello J
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32375361
[TBL] [Abstract][Full Text] [Related]
2. Lipid nanoparticle delivery of a microRNA-145 inhibitor improves experimental pulmonary hypertension.
McLendon JM; Joshi SR; Sparks J; Matar M; Fewell JG; Abe K; Oka M; McMurtry IF; Gerthoffer WT
J Control Release; 2015 Jul; 210():67-75. PubMed ID: 25979327
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA Therapeutics: the Next Magic Bullet?
Simonson B; Das S
Mini Rev Med Chem; 2015; 15(6):467-74. PubMed ID: 25807941
[TBL] [Abstract][Full Text] [Related]
4. Non-coding RNAs: Therapeutic Strategies and Delivery Systems.
Ling H
Adv Exp Med Biol; 2016; 937():229-37. PubMed ID: 27573903
[TBL] [Abstract][Full Text] [Related]
5. Enhancing the Therapeutic Delivery of Oligonucleotides by Chemical Modification and Nanoparticle Encapsulation.
Sun Y; Zhao Y; Zhao X; Lee RJ; Teng L; Zhou C
Molecules; 2017 Oct; 22(10):. PubMed ID: 29027965
[TBL] [Abstract][Full Text] [Related]
6. RNA-targeted therapeutics in cancer clinical trials: Current status and future directions.
Barata P; Sood AK; Hong DS
Cancer Treat Rev; 2016 Nov; 50():35-47. PubMed ID: 27612280
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA therapeutics: principles, expectations, and challenges.
Rupaimoole R; Han HD; Lopez-Berestein G; Sood AK
Chin J Cancer; 2011 Jun; 30(6):368-70. PubMed ID: 21627858
[TBL] [Abstract][Full Text] [Related]
8. Oligonucleotide-based theranostic nanoparticles in cancer therapy.
Shahbazi R; Ozpolat B; Ulubayram K
Nanomedicine (Lond); 2016 May; 11(10):1287-308. PubMed ID: 27102380
[TBL] [Abstract][Full Text] [Related]
9. Nanomedicine Meets microRNA: Current Advances in RNA-Based Nanotherapies for Atherosclerosis.
Gadde S; Rayner KJ
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):e73-9. PubMed ID: 27559146
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA Delivery Strategies to the Lung in a Model of Pulmonary Hypertension.
Deng L; Baker AH; Bradshaw AC
Methods Mol Biol; 2017; 1521():325-338. PubMed ID: 27910060
[TBL] [Abstract][Full Text] [Related]
11. MiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: A new multimodal gene therapy approach for glioblastoma.
Costa PM; Cardoso AL; Custódia C; Cunha P; Pereira de Almeida L; Pedroso de Lima MC
J Control Release; 2015 Jun; 207():31-9. PubMed ID: 25861727
[TBL] [Abstract][Full Text] [Related]
12. Reversal of MicroRNA Dysregulation in an Animal Model of Pulmonary Hypertension.
Gubrij IB; Pangle AK; Pang L; Johnson LG
PLoS One; 2016; 11(1):e0147827. PubMed ID: 26815432
[TBL] [Abstract][Full Text] [Related]
13. Targeting and delivery of microRNA-targeting antisense oligonucleotides in cardiovascular diseases.
Saenz-Pipaon G; Dichek DA
Atherosclerosis; 2023 Jun; 374():44-54. PubMed ID: 36577600
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticle Delivery Systems for DNA/RNA and their Potential Applications in Nanomedicine.
Shen H; Huang X; Min J; Le S; Wang Q; Wang X; Dogan AA; Liu X; Zhang P; Draz MS; Xiao J
Curr Top Med Chem; 2019; 19(27):2507-2523. PubMed ID: 31775591
[TBL] [Abstract][Full Text] [Related]
15. Human lung microRNA profiling in pulmonary arterial hypertension secondary to congenital heart defect.
Ma K; Zhao Q; Chen W; Zhang H; Li S; Pan X; Chen Q
Pediatr Pulmonol; 2015 Dec; 50(12):1214-23. PubMed ID: 25847058
[TBL] [Abstract][Full Text] [Related]
16. Bio-inspired materials in drug delivery: Exploring the role of pulmonary surfactant in siRNA inhalation therapy.
De Backer L; Cerrada A; Pérez-Gil J; De Smedt SC; Raemdonck K
J Control Release; 2015 Dec; 220(Pt B):642-50. PubMed ID: 26363301
[TBL] [Abstract][Full Text] [Related]
17. Emerging Role of MicroRNAs and Long Noncoding RNAs in Healthy and Diseased Lung.
Xiao JH; Hao QY; Wang K; Paul J; Wang YX
Adv Exp Med Biol; 2017; 967():343-359. PubMed ID: 29047098
[TBL] [Abstract][Full Text] [Related]
18. Targeting microRNA-134 for seizure control and disease modification in epilepsy.
Morris G; Reschke CR; Henshall DC
EBioMedicine; 2019 Jul; 45():646-654. PubMed ID: 31300345
[TBL] [Abstract][Full Text] [Related]
19. [Pulmonary hypertension: microRNAs in pathogenesis, diagnosis and therapy].
Huber LC; Leuenberger C; Kohler M; Brock M
Pneumologie; 2014 Jun; 68(6):386-93. PubMed ID: 24715431
[TBL] [Abstract][Full Text] [Related]
20. Endothelial nanomedicine for the treatment of pulmonary disease.
Brenner JS; Greineder C; Shuvaev V; Muzykantov V
Expert Opin Drug Deliv; 2015 Feb; 12(2):239-61. PubMed ID: 25394760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
